Literature DB >> 12149382

Detection of enteroaggregative Escherichia coli with formalin-preserved HEp-2 cells.

Mohamad S Miqdady1, Zhi-Dong Jiang, James P Nataro, Herbert L DuPont.   

Abstract

Formalin-stored HEp-2 cells were used to assay Escherichia coli for adherence. Cells refrigerated in formalin for up to 28 days and used in a wet assay format demonstrated an assay sensitivity ranging from 94 to 98% to detect enteroaggregative E. coli (EAEC). HEp-2 cells first fixed and stored with formalin and then stored dry in ambient conditions for 6 weeks demonstrated an assay sensitivity of 92% to detect EAEC. Using formalin-fixed HEp-2 cells will improve the efficiency of EAEC identification.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12149382      PMCID: PMC120651          DOI: 10.1128/JCM.40.8.3066-3067.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Adhesion of enteroaggregative Escherichia coli to formalin-fixed intestinal and ureteric epithelia from children.

Authors:  S Hicks; D C Candy; A D Phillips
Journal:  J Med Microbiol       Date:  1996-05       Impact factor: 2.472

2.  Enteroadherent Escherichia coli as a cause of diarrhea among children in Mexico.

Authors:  J J Mathewson; R A Oberhelman; H L Dupont; F Javier de la Cabada; E V Garibay
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

3.  Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world.

Authors:  J A Adachi; Z D Jiang; J J Mathewson; M P Verenkar; S Thompson; F Martinez-Sandoval; R Steffen; C D Ericsson; H L DuPont
Journal:  Clin Infect Dis       Date:  2001-05-21       Impact factor: 9.079

4.  Improved detection of enteroaggregative Escherichia coli using formalin-fixed HEp-2 cells.

Authors:  J Spencer; H Chart; H R Smith; B Rowe
Journal:  Lett Appl Microbiol       Date:  1997-11       Impact factor: 2.858

5.  Enteroaggregative Escherichia coli produce intestinal inflammation and growth impairment and cause interleukin-8 release from intestinal epithelial cells.

Authors:  T S Steiner; A A Lima; J P Nataro; R L Guerrant
Journal:  J Infect Dis       Date:  1998-01       Impact factor: 5.226

6.  Enteroaggregative Escherichia coli as a cause of traveler's diarrhea: clinical response to ciprofloxacin.

Authors:  M Glandt; J A Adachi; J J Mathewson; Z D Jiang; D DiCesare; D Ashley; C D Ericsson; H L DuPont
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

7.  Natural history of enteroaggregative and enterotoxigenic Escherichia coli infection among US travelers to Guadalajara, Mexico.

Authors:  Javier A Adachi; Charles D Ericsson; Zhi-Dong Jiang; Margaret W DuPont; Sanjay R Pallegar; Herbert L DuPont
Journal:  J Infect Dis       Date:  2002-05-17       Impact factor: 5.226

8.  Entero-adherent Escherichia coli is an important diarrhoeagenic agent in infants aged below 6 months in Calcutta, India.

Authors:  A R Ghosh; G B Nair; T N Naik; M Paul; S C Pal; D Sen
Journal:  J Med Microbiol       Date:  1992-04       Impact factor: 2.472

9.  Enteroaggregative Escherichia coli may be a new pathogen causing acute and persistent diarrhea.

Authors:  S Bhatnagar; M K Bhan; H Sommerfelt; S Sazawal; R Kumar; S Saini
Journal:  Scand J Infect Dis       Date:  1993

10.  A newly recognized cause of travelers' diarrhea: enteroadherent Escherichia coli.

Authors:  J J Mathewson; P C Johnson; H L DuPont; D R Morgan; S A Thornton; L V Wood; C D Ericsson
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

View more
  2 in total

1.  Multiplex PCR for detection of three plasmid-borne genes of enteroaggregative Escherichia coli strains.

Authors:  Jorge F Cerna; James P Nataro; Teresa Estrada-Garcia
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

2.  Enteroaggregative Escherichia coli: An Emerging Pathogen.

Authors:  David B. Huang; Hoonmo Koo; Herbert L. DuPont
Journal:  Curr Infect Dis Rep       Date:  2004-04       Impact factor: 3.725

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.